Home > Publications > Medical Specialty > Internal Medicine > Haematology > Multiple Myeloma > Multiple Myeloma Research Review, Issue 70
Multiple Myeloma Research Review, Issue 70

Multiple Myeloma Research Review, Issue 70

In this issue:

Updated Australian transplant guidelines
Dexamethasone-sparing regimen prolongs PFS in frail patients
Sequential bispecific–CAR-T approach feasible for RR disease
Tocilizumab prophylaxis mitigates CRS in patients undergoing bispecific treatment
Cilta-cel bests real-world treatments for lenalidomide-refractory disease
European experts deem outpatient bispecific treatment feasible
Daratumumab-lenalidomide maintenance beneficial regardless of risk status
Hybrid modality whole-body PET/MRI may aid identification of high-risk SMM

You need to be logged in to access this content.

Adam-Bryant

Expert contributor

Dr Adam Bryant

Adam is a Senior Staff Specialist Haematologist at Liverpool Hospital in South West Sydney and is proud to be affiliated as a Conjoint Senior Lecturer with the University of New South Wales. More broadly, Adam is current Treasurer and NSW Councillor of the Haematology Society of Australia and New Zealand, which is involved in advocacy […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.